Cecropin P1 inhibits porcine reproductive and respiratory syndrome virus by blocking attachment

BMC Microbiology

Zuyong He²  Yaosheng Chen²  Xiaohong Liu²  Peiqing Cong²  Yumao Huang¹  Chunhe Guo² 

[1] College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, Guangdong, PR China;State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third road, Guangzhou Higher Education Mega Center, Guangzhou 510006, Guangdong, PR China

关键词: Antimicrobial peptide;    Antiviral activity;    PRRSV;    Cecropin P1;   

Others  :  1137734
DOI  :  10.1186/s12866-014-0273-8

 received in 2014-06-12, accepted in 2014-10-23,  发布年份 2014

【 摘 要 】

Background

Porcine reproductive and respiratory syndrome virus (PRRSV) is a continuous threat to the pig industry, causing high economic losses worldwide. Current vaccines have specific limitations in terms of their safety and efficacy, so the development of novel antiviral drugs is urgently required. The aim of this study was to evaluate the inhibitory effects and underlying molecular mechanisms of the antimicrobial peptide cecropin P1 (CP1) against PRRSV infection in vitro.

Results

CP1 not only displayed extracellular virucidal activity against PRRSV, but also exerted a potent inhibitory effect when added either before, simultaneously with, or after viral inoculation. The inhibitory effect of CP1 occurred during viral attachment, but not at viral entry into Marc-145 cells. CP1 also inhibited viral particle release and attenuated virus-induced apoptosis during the late phase of infection. CP1 exerted similar inhibitory effects against PRRSV infection in porcine alveolar macrophages, the cells targeted by the virus in vivo during its infection of pigs. The expression of interleukin 6 was elevated by CP1 in porcine alveolar macrophages, which might contribute to its inhibition of PRRSV infection.

Conclusions

Collectively, our findings provide a new direction for the development of potential therapeutic drugs against PRRSV infection.

【 授权许可】

   
2014 Guo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 8.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 2.

【 参考文献 】

• [1]Van Breedam W, Van Gorp H, Zhang JQ, Crocker PR, Delputte PL, Nauwynck HJ: The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS Pathog 2010, 6(1):e1000730.
• [2]Wensvoort G, Terpstra C, Pol JM, ter Laak EA, Bloemraad M, de Kluyver EP, Kragten C, van Buiten L, den Besten A, Wagenaar F, Broekhuijsen JM, Moonen PL, Zetstra T, de Boer EA, Tibben HJ, de Jong MF, van’t Veld P, Greenland GJ, van Gennep JA, Voets MT, Verheijden JH, Braamskamp J: Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q 1991, 13(3):121-130.
• [3]Zhao C, Liu S, Li C, Yang L, Zu Y: In vitro evaluation of the antiviral activity of the synthetic epigallocatechin gallate analog-epigallocatechin gallate (EGCG) palmitate against porcine reproductive and respiratory syndrome virus. Viruses 2014, 6(2):938-950.
• [4]Kuzemtseva L, de la Torre E, Martin G, Soldevila F, Ait-Ali T, Mateu E, Darwich L: Regulation of toll-like receptors 3, 7 and 9 in porcine alveolar macrophages by different genotype 1 strains of porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2014, 158(3–4):189-198.
• [5]Johnson CR, Griggs TF, Gnanandarajah J, Murtaugh MP: Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J Gen Virol 2011, 92(Pt 5):1107-1116.
• [6]Hu J, Ni Y, Dryman BA, Meng XJ, Zhang C: Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 2012, 30(12):2068-2074.
• [7]Wang L, Xiao S, Gao J, Liu M, Zhang X, Li M, Zhao G, Mo D, Liu X, Chen Y: Inhibition of replication of porcine reproductive and respiratory syndrome virus by hemin is highly dependent on heme oxygenase-1, but independent of iron in MARC-145 cells. Antiviral Res 2014, 105:39-46.
• [8]Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276(11):7806-7810.
• [9]Peters BM, Shirtliff ME, Jabra-Rizk MA: Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 2010, 6(10):e1001067.
• [10]Chiou PP, Lin CM, Perez L, Chen TT: Effect of cecropin B and a synthetic analogue on propagation of fish viruses in vitro. Mar Biotechnol (NY) 2002, 4(3):294-302.
• [11]Chiou PP, Chen MJ, Lin CM, Khoo J, Larson J, Holt R, Leong JA, Thorgarrd G, Chen TT: Production of homozygous transgenic rainbow trout with enhanced disease resistance. Mar Biotechnol (NY) 2014, 16(3):299-308.
• [12]Costers S, Lefebvre DJ, Delputte PL, Nauwynck HJ: Porcine reproductive and respiratory syndrome virus modulates apoptosis during replication in alveolar macrophages. Arch Virol 2008, 153(8):1453-1465.
• [13]Kumar N, Liang YH, Parslow TG, Liang YY: Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol 2011, 85(6):2818-2827.
• [14]Jourdan SS, Osorio FA, Hiscox JA: Biophysical characterisation of the nucleocapsid protein from a highly pathogenic porcine reproductive and respiratory syndrome virus strain. Biochem Biophys Res Commun 2012, 419(2):137-141.
• [15]Music N, Gagnon CA: The role of porcine reproductive and respiratory syndrome (PRRS) virus structural and non-structural proteins in virus pathogenesis. Anim Health Res Rev 2010, 11(2):135-163.
• [16]Pejsak Z, Stadejek T, Markowska-Daniel I: Clinical signs and economic losses caused by porcine reproductive and respiratory syndrome virus in a large breeding farm. Vet Microbiol 1997, 55(1–4):317-322.
• [17]Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ: Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc 2005, 227(3):385-392.
• [18]Xiao ZG, Batista L, Dee S, Halbur P, Murtaugh MP: The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. J Virol 2004, 78(11):5923-5933.
• [19]Murtaugh MP, Xiao ZG, Zuckermann F: Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 2002, 15(4):533-547.
• [20]Thanawongnuwech R, Suradhat S: Taming PRRSV: revisiting the control strategies and vaccine design. Virus Res 2010, 154(1–2):133-140.
• [21]Moore AJ, Beazley WD, Bibby MC, Devine DA: Antimicrobial activity of cecropins. J Antimicrob Chemother 1996, 37(6):1077-1089.
• [22]Zhou YL, Peng Y: Synergistic effect of clinically used antibiotics and peptide antibiotics against gram-positive and gram-negative bacteria. Exp Ther Med 2013, 6(4):1000-1004.
• [23]Hoffmann J, Schneider C, Heinbockel L, Brandenburg K, Reimer R, Gabriel G: A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment. Antiviral Res 2014, 104:23-33.
• [24]Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI: Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 2004, 78(10):5147-5156.
• [25]Zhang L, Liu J, Bai J, Du Y, Wang X, Liu X, Jiang P: Poly(I:C) inhibits porcine reproductive and respiratory syndrome virus replication in MARC-145 cells via activation of IFIT3. Antiviral Res 2013, 99(3):197-206.
• [26]Qiao SL, Feng LL, Bao DK, Guo JQ, Wan B, Xiao ZJ, Yang SZ, Zhang GP: Porcine reproductive and respiratory syndrome virus and bacterial endotoxin act in synergy to amplify the inflammatory response of infected macrophages. Vet Microbiol 2011, 149(1–2):213-220.
• [27]Delogu I, Pastorino B, Baronti C, Nougairede A, Bonnet E, de Lamballerie X: In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antiviral Res 2011, 90(3):99-107.
• [28]Patel D, Stein DA, Zhang YJ: Morpholino oligomer-mediated protection of porcine pulmonary alveolar macrophages from arterivirus-induced cell death. Antivir Ther 2009, 14(7):899-909.
• [29]Hudjetz B, Gabriel G: Human-like PB2 627 K influenza virus polymerase activity is regulated by importin-alpha1 and -alpha7. PLoS Pathog 2012, 8(1):e1002488.
• [30]Yang Q, Gao L, Si J, Sun Y, Liu J, Cao L, Feng WH: Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid AB. Antiviral Res 2013, 97(1):66-73.
• [31]Hong W, Li T, Song Y, Zhang R, Zeng Z, Han S, Zhang X, Wu Y, Li W, Cao Z: Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. Antiviral Res 2014, 102:1-10.